Can Anybody Stop The Acquisition Of Elan Corporation, plc (ADR) (NYSE:ELN)?


Dallas, Texas 12/16/2013 (FINANCIALSTRENDS) – It looks like that nobody can stop the takeover of Elan Corporation, plc (ADR) (NYSE:ELN) to be done by the Perrigo Company. All the indications are showing that nothing can stop this acquisition process. All this have lead to an 0.19% fall in the stock price of Elan Corporation on Friday and the closed down at $16.01. Now the investors are looking at the Monday for the price range of this stock.

As per the acquisition process Perrigo Company will pay about $6.7 billion to Elan Corporation. However there has been loads of heat that has generated during the entire process. Elan Corporation is basically a biotech company and the current market capitalization stands at $8.21 billion. The company is also planning to do several asset purchase agreements.

Hedge Funds seems to be bullish about Elan Corporation, plc (ADR) (NYSE:ELN)

There are many hedge fund managers that seem to be quite bullish about the Elan Corporation and the main reason behind this bullishness is that the company has transferred it major chunk of the drug delivery business to a new company and as a result the investor value has also increased. The company even purchased the IP that is related to Tysabri from another company on February this year. As per the current situation there are over 75,000 patients on Tysabri therapy and are projected to increase by a significant number in the coming years.

Under its acquisition theory it seems that the entire acquisition process is moving at a very fast pace and all the formalities will be completed very soon.  As per more information the company is also planning to discover and develop various advanced therapies that are being used for the treatment of neurodegenerative diseases. All these news seems to be working in the favor of the company.